ClinicalTrials.gg
CompletedNCT05942183Updated Sep 5, 2024

Optic Nerve Sheath Diameter is Associated With Postoperative Delirium in Patients Undergoing Open Heart Surgery

An observational study in Delirium, Postoperative, Cardiac Disease and Cardiac Valve Disease, sponsored by Samsun University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-09-05.

Sponsored by Samsun University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
90
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Although the incidence of delirium after cardiac surgery is high, it is not sufficiently recognized. The long-term effects of delirium are likely to be underestimated. In this study, the investigators aimed to examine the relationship between optic nerve sheath diameter and postoperative delirium in open hearth surgery.

Read the detailed description

Postoperative delirium is characterized by widespread brain involvement and its incidence is between 6% and 30%. It appears twice as often after cardiac and vascular surgery than other types of surgery. The correlation between optic nerve sheath diameter (ONSD) and invasive intracranial pressure measurement is excellent. ONSD reduction has the potential to indicate intracranial hypoperfusion causing delirium. In this observational study, patients aged 18 years and over who will undergo open heart surgery will be examined. ONSD will be measured using ultrasound five times in the perioperative period (t0: pre-induction, t1: post-induction, t2: onset of cardiopulmonary bypass (CPB), t3: post-CPB, and t4: post-ICU admission). The Confusion Assessment Method for the ICU (CAM-ICU) test will be used to examine delirium in the ICU. Whether the change in ONSD is an independent risk factor for delirium will be evaluated.

02

Conditions studied

  • Delirium, Postoperative
  • Cardiac Disease
  • Cardiac Valve Disease

Keywords

  • optic nerve sheath diameter
  • cardiac surgery
  • ultrasound
03

In context

Emergence Delirium

788 studies on the registry are indexed under Emergence Delirium; 250 are open to participants now.

This study's enrollment of 90 is below the median of 154 across 288 observational studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Samsun University is the lead sponsor of 86 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients over the age of 18 who will undergo elective open heart surgery will be included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥18 year old
  • Elective open heart surgery

Exclusion criteria

Exclusion Criteria:

  • psychiatric illness
  • neurological disease
  • ophthalmic disease
  • previous eye surgery
  • perioperative cerebrovascular disease
  • need for postoperative intraaortic balloon or extracorporeal support system
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
90 participants (actual)
Patient registry
No

Groups and cohorts

  • CAM-ICU positive

    delirium positive

    Diagnostic Test: ONSD

  • CAM-ICU negative

    delirium negative

    Diagnostic Test: ONSD

Interventions

  • Diagnostic testONSD

    ultrasound measurement of the optic nerve sheath diameter

06

What researchers measure

Primary outcomes

  1. The relationship between ONSD and postoperative delirium in cardiac surgery

    Peroperatively measured ONSD will be compared with the development of postoperative delirium.

    Time frame: 6 months

  2. Incidence of delirium after open heart surgery

    Using the CAM-ICU test for delirium definition

    Time frame: 6 months

07

Study locations

1 site
  • Aynur Kaynar
    Samsun, 55270, Turkey (Türkiye)
08

References and documents

Publications

  • Heyer EJ, DeLaPaz R, Halazun HJ, Rampersad A, Sciacca R, Zurica J, Benvenisty AI, Quest DO, Todd GJ, Lavine S, Solomon RA, Connolly ES Jr. Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery. 2006 Mar;58(3):474-80; discussion 474-80. doi: 10.1227/01.NEU.0000197123.09972.EA. PubMed 16528187 ↗
  • Smith W, Whitlock EL. Cardiac surgery, ICU sedation, and delirium: is dexmedetomidine the silver bullet? Curr Opin Anaesthesiol. 2023 Feb 1;36(1):50-56. doi: 10.1097/ACO.0000000000001207. Epub 2022 Nov 7. PubMed 36342329 ↗
  • Zhang X, Medow JE, Iskandar BJ, Wang F, Shokoueinejad M, Koueik J, Webster JG. Invasive and noninvasive means of measuring intracranial pressure: a review. Physiol Meas. 2017 Jul 24;38(8):R143-R182. doi: 10.1088/1361-6579/aa7256. PubMed 28489610 ↗
  • Sekhon MS, Griesdale DE, Robba C, McGlashan N, Needham E, Walland K, Shook AC, Smielewski P, Czosnyka M, Gupta AK, Menon DK. Optic nerve sheath diameter on computed tomography is correlated with simultaneously measured intracranial pressure in patients with severe traumatic brain injury. Intensive Care Med. 2014 Sep;40(9):1267-74. doi: 10.1007/s00134-014-3392-7. Epub 2014 Jul 18. PubMed 25034476 ↗
  • Kaynar A, Komurcu O, Bahsi E, Aydin AO, Karal IH, Akyurt D, Tulgar S, Suren M. Optic nerve sheath diameter is associated with postoperative delirium in patients undergoing open heart surgery. BMC Anesthesiol. 2025 Jul 1;25(1):309. doi: 10.1186/s12871-025-03194-9. PubMed 40596877 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2023 to primary completion in Jun 2024, 10 months.

Of 187 non-industry observational studies under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's 10 months is below that.

Counting every sponsor, half of 188 studies reached it within 20 months; a quarter within 10 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2023
First posted
Jul 12, 2023
StartActual
Aug 7, 2023
Primary completionActual
Jun 12, 2024
CompletionActual
Jun 12, 2024
Last update
Sep 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05942183
Lead sponsor
Samsun University
Responsible party
Aynur Kaynar (principle investigator, Samsun University) — Principal investigator
First posted
Jul 12, 2023
Start date
Aug 7, 2023
Primary completion
Jun 12, 2024
Completion
Jun 12, 2024
Last update
Sep 5, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion